ProBioGen signs commercial license agreement with AstraZeneca providing their GlymaxX technology
ProBioGen has inked a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology.
If you are not happy with the results below please do another search
ProBioGen has inked a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology.